We reported in a previous work that insulin degradation by insulin-degrading enzyme (IDE) was inhibited by ATP (Exp Biol Med 226:334–341, 2001). Then we studied ATP hydrolysis as a possible mechanism for reversion of this inhibition. ATP hydrolysis was determined by 32P release after hydrolysis of γ[32P]ATP. ATP hydrolysis was studied by Sephadex G200 chromatography, immunoprecipitation, and nondissociating gel electrophoresis. Purified recombinant rat IDE and extractive homogenous IDE showed similar ATP hydrolysis. All results showed concordance between insulin degradation and ATP hydrolysis, suggesting that IDE has both functions. In order to define the type of hydrolysis, we studied inhibitors of IDE, phosphohydrolases, and ATPases. Each substance studied had no effect on ATP hydrolysis, except 1 mM orthovanadate, a known inhibitor of ATPases, phosphatases, and insulin degradation. ATP hydrolysis followed a Michaelis-Menten kinetic with Vmax: 570.45 ± 113.08 pmol Pi/hr and apparent Michaelis constant (Km): 63.13 ± 3.48 μM. ATP binding studies strongly suggested an ATP binding site and enzyme kinetics established only one active hydrolytic ATP binding site per IDE molecule. ATP-induced enzyme aggregation changes as observed by electrophoresis mobility in nondissociating conditions and conformational changes on insulin binding as shown by IDE-insulin cross-linking. We conclude that IDEs have ATPase activity and that insulin-binding and degradation are dependent on ATP concentration; however, insulin does not modify the ATPase activity of IDE.
Get full access to this article
View all access options for this article.
References
1.
Mirsky A. IV Hormone chemistry and metabolism: insulinase, insulinase inhibitors and diabetes mellitus. Recent Prog Horm Res13:429–471, 1957.
2.
Affholter JA, Fried VA, Roth RA. Human insulin-degrading enzyme shares structural and functional homologies with E. coli Portease III. Science242:1415–1418, 1988.
3.
Baumeister H, Muller D, Rehbein M, Ritcher D. The rat insulin-degrading enzyme: molecular cloning and characterization of tissue-specific transcripts. FEBS317:250–254, 1993.
4.
Bennet RG, Hamel FG, Duckworth WC. Characterization of the insulin inhibition of the peptidolytic activies of the insulin degrading enzyme-proteosome complex. Diabetes46:197–203, 1997.
5.
Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, Rosner MR. Safavi A, Hersh LB, Selkoe DJ. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem273:32730–32738, 1998.
6.
Authier F, Bergeron JJM, Ou WJ, Rachubinski RA, Posner BI, Walton RA. Degradation of the cleaved leader peptide of thiolase by a peroxisomal proteinase. Proc Natl Acad Sci U S A92:3859–3863, 1995.
Kurochkin IV. Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme. FEBS Lett427:153–156, 1998.
9.
Fakhrai-Rad H, Nikoshkov A, Kamel A, Fernström M, Zierath JR, Norgren S, Luthman H, Galli J. Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. Hum Mol Gen14: 2149–2158, 2000.
10.
Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guénette S. Insulin-degrading enzyme regulates the levels of insulin, amyloid ß-protein and the ß-amyloid precursor protein intracellular domain in vivo.Proc Natl Acad Sci U S A100:4162–4167, 2003.
Terris S, Steiner DF. Binding y degradación de 125I-insulina by rat hepatocytes. J Biol Chem250:8389–8398, 1975.
13.
Udrisar DP, Camberos MC, Basabe JC, Cresto JC. Insulin processing, its correlation with glucosa conversion to CO2. Acta Physiol Pharmacol Latinoam.34:427–440, 1984.
14.
Hamel FG, Upward JL, Bennett RG. In vitro inhibition of insulin-degrading enzyme by long-chain fatty acids and their coenzyme A thioesters. Endocrinology144:2404–2408, 2003.
15.
Cresto JC, Udrisar DP, Camberos MC, Basabe JC, Gomez Acuña P, de Majo SF. Preparation of biologically active mono-125I-insulin of high specific activity. Acta Physiol Latinoam31:13–24, 1981.
16.
Duckworth WC, Heinemann M, Kitabchi AE. Proteolytic degradation of insulin and glucagon. Biochim Biophys Acta377:421–430, 1975.
17.
Suzuki K, Kono T. Internalization and degradation of fat cell-bound insulin: separation and partial characterization of subcellular vesicles associated with iodoinsulin. J Biol Chem254:9786–9794, 1979.
18.
Levy JR, Olefsky JM. Retroendocitosis of insulin in rat adipocytes. Endocrinology119:572–579, 1986.
19.
Rossi JP, Gronda CM, Fernandez HN, Gagliardino JJ. Characteristics of a Ca2+-ATPase activity measured in islet homogenates. Biochim Biophys Acta943:175–182, 1988.
20.
Hames BD, Rickwood D, Eds. Gel electrophoresis of proteins: A practical approach (2nd ed.). New York: Oxford University Press, 1990.
21.
Biwas S, Biwas EE. Regulation of dnaB function in DNA replication in Escherichia coli by dnaC and λP gene products. J Biol Chem262: 7831–7838, 1987.
22.
Shii K, Baba S, Yokono K, Roth RA. Covalent linkage of 125I insulin to a cytosolic insulin-degrading enzyme. J Biol Chem260:6503–6506, 1985.
23.
Song ES, Juliano MA, Juliano L, Fried MG, Wagner SL, Hersh LB. ATP effects on insulin-degrading enzyme are mediated primarily through its triphosphate moiety. J Biol Chem279:54216–54220, 2004.
24.
Ebrahim A, Hamel FG, Bennet RG, Duckworth WC. Identification of metal associated with the insulin degrading enzyme. Biochem Biophys Res Commun181:1398–1406, 1991.
25.
Duranti M, Scarafoni A, Di Cataldo A, Sessa F. Interaction of metal ions with lupin seed conglutin gamma. Phytochemistry56:529–533, 2001.
26.
Sun G, Budde RJ. Affinity purification of Csk protein tyrosine kinase based on its catalytic requirement for divalent metal cations. Protein Expr Purif21:8–12, 2001.
27.
Ferris JP, Ertem G. Oligomerization reaction of ribonucleotides: the reaction of the 5′-phosphorimodasolide of nucleosides on montmorillonite and other minerals. Orig Life Evol Biosph22:369–381, 1992.
28.
Weber J, Senior AE. Location and properties of pyrophosphate-binding sites in Escherichia coli F1-ATPase. J Biol Chem270:12653–12658, 1995.
29.
Yu ZW, Posner BI, Smith U, Eriksson JW. Effects of peroxovanadate and vanadate on insulin binding, degradation and sensitivity in rat adipocytes. Biochim Biophys Acta1310:103–109, 1996.
30.
Song ES, Juliano MA, Juliano L, Hersh LB. Substrate activation of insulin degrading-enzyme (insulysin) potential target for drug development. J Biol Chem278:49789–49794, 2003.
31.
Perlman RK, Gehn BD, Kuo WI, Rosner MR. Functional analysis of conserved residues in the active site of insulin-degrading enzyme. J Biol Chem268:21538–21544, 1993.
32.
Doolittle RF, Johnson MS, Husain L, Van Houten B, Thomas DC, Sancar A. Domainal evolution of a prokaryotic DNA repair protein and its relationship to active-transport proteins. Nature323:451–453, 1986.
33.
Marcu MG, Chadli A, Bouhouche I, Catelli M, Neckers LM. The heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone. J Biol Chem275:37181–37186, 2000.
34.
Taylor SS, Buechler JA, Yonemoto W. cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu Rev Biochem59:971–1005, 1990.
35.
Jurnak F, Heffron S, Bergmann E. Conformational changes involved in the activation of ras p21: implications for related proteins. Cell60:525–528, 1990.
36.
Goldfine ID. The insulin receptor: molecular biology and trans-membrane signaling. Endocr Rev8:235–255, 1987.
37.
Diamant S, Azem A, Weiss C, Goloubinoff P. Effect of free and ATP-bound magnesium and manganese ions on the ATPase activity of Chaperonin GroE. Biochemistry34:273–277, 1995.
38.
Hayes SA, Fred Dice J. Roles of molecular chaperones in protein degradation. J Cell Biol132:255–258, 1996.
39.
Kaser M, Langer T. Protein degradation in mitochondria. Sem Cell Dev Biol11:181–190, 2000.
40.
Perez A, Zuazquita A, Camberos MC, Udrisar DP, Cresto JC. Insulin-degrading activity is present in mitochondrial matrix. Diabetes47(Suppl 1):1559, 1998.
41.
Leissring MA, Farris W, Wu X, Christodoulou DC, Haigis MC, Guarente L, Selkoe DJ. Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria. Biochem J383:439–446, 2004.
42.
Nagao Y, Kitada S, Kojima K, Toh H, Kuhara S, Ogishima T, Ito A. Glycine-rich region of mitochondrial processing peptidase α-subunit is essential for binding and cleavage of the precursor proteins. J Biol Chem275:34552–34556, 2000.
43.
Hamel FG, Bennet RG, Upward JL, Duckworth WC. Insulin inhibits peroxisomal fatty acid oxidation in isolated rat hepatocytes. Endocrinology142:2702–2706, 2001.
